JAKARTA, Indonesia, March 31, 2016 /PRNewswire/ -- Publicly listed Merck, founded in 1970 as the Indonesian unit of a German-based pharmaceutical giant, expects double-digit growth in total sales in 2016 following a similar growth in its healthcare business last year. The biopharma business, for example, rose by 14.5 percent in 2015, above the industry average of 8 to 9 percent. On the other hand, the consumer health business soared by 16 percent (Source: Jakarta Post).
The company will also strengthen its current strategy of maintaining partnerships with both private and government organizations such as the Health Ministry and the Jakarta Administration. Through which, Merck will expand public awareness about health issues, encourage public acceptance and broaden market access for Merck's pharmaceutical products.
Merck is also currently expanding the production capacity of its factory in TB Simatupang, South Jakarta, to further boost future sales.
These and other key industry news will be discussed next week at CPhI SEA, the only trade exhibition dedicated to the pharma industry in the region, held at Jakarta International Expo during April 6-8, 2016. Don't miss the opportunity to be part of the change, register here and join the event!
The CPhI series of events supports growth and innovation in the global pharmaceutical industry, with leading exhibitions and online communities covering every step of the supply chain from drug discovery to finished dosage.
More than 100,000 visitors meet over 6,000 exhibitors at events in Europe, China, India, Japan, South East Asia, Russia, Brazil, Istanbul and Korea every year to exchange ideas, form alliances and conduct business on an international scale. CPhI also provides an online buyer & supplier directory at CPhI-Online.com.
Phone Number: +62-21-2930-5959 ext 138
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/indonesian-pharma-merck-sees-healthy-growth-ahead-300243887.html
SOURCE CPhI - UBM